Your browser doesn't support javascript.
loading
Preclinical characterisation of the GM-CSF receptor as a therapeutic target in rheumatoid arthritis.
Greven, D E A; Cohen, E S; Gerlag, D M; Campbell, J; Woods, J; Davis, N; van Nieuwenhuijze, A; Lewis, A; Heasmen, S; McCourt, M; Corkill, D; Dodd, A; Elvin, J; Statache, G; Wicks, I P; Anderson, I K; Nash, A; Sleeman, M A; Tak, P P.
Afiliação
  • Greven DE; Department of Clinical Immunology and Rheumatology, Academic Medical Center/ University of Amsterdam, Amsterdam, The Netherlands.
  • Cohen ES; Department of Respiratory, Inflammation and AutoImmunity Research, MedImmune Limited, Cambridge, UK.
  • Gerlag DM; Department of Clinical Immunology and Rheumatology, Academic Medical Center/ University of Amsterdam, Amsterdam, The Netherlands GlaxoSmithKline, Cambridge, UK.
  • Campbell J; Department of Respiratory, Inflammation and AutoImmunity Research, MedImmune Limited, Cambridge, UK.
  • Woods J; Department of Respiratory, Inflammation and AutoImmunity Research, MedImmune Limited, Cambridge, UK.
  • Davis N; Department of Respiratory, Inflammation and AutoImmunity Research, MedImmune Limited, Cambridge, UK.
  • van Nieuwenhuijze A; Inflammation Division, The Walter and Eliza Hall Institute of Medical Research, Parkville, Victoria, Australia.
  • Lewis A; Department of Respiratory, Inflammation and AutoImmunity Research, MedImmune Limited, Cambridge, UK.
  • Heasmen S; Department of Respiratory, Inflammation and AutoImmunity Research, MedImmune Limited, Cambridge, UK.
  • McCourt M; Department of Respiratory, Inflammation and AutoImmunity Research, MedImmune Limited, Cambridge, UK.
  • Corkill D; Department of Respiratory, Inflammation and AutoImmunity Research, MedImmune Limited, Cambridge, UK.
  • Dodd A; Department of Respiratory, Inflammation and AutoImmunity Research, MedImmune Limited, Cambridge, UK.
  • Elvin J; Department of Respiratory, Inflammation and AutoImmunity Research, MedImmune Limited, Cambridge, UK.
  • Statache G; Department of Clinical Immunology and Rheumatology, Academic Medical Center/ University of Amsterdam, Amsterdam, The Netherlands.
  • Wicks IP; Inflammation Division, The Walter and Eliza Hall Institute of Medical Research, Parkville, Victoria, Australia.
  • Anderson IK; Department of Respiratory, Inflammation and AutoImmunity Research, MedImmune Limited, Cambridge, UK.
  • Nash A; Department of Research and Development, CSL Limited, Parkville, Victoria, Australia.
  • Sleeman MA; Department of Respiratory, Inflammation and AutoImmunity Research, MedImmune Limited, Cambridge, UK.
  • Tak PP; Department of Clinical Immunology and Rheumatology, Academic Medical Center/ University of Amsterdam, Amsterdam, The Netherlands GlaxoSmithKline, Stevenage, UK University of Cambridge, Cambridge, UK.
Ann Rheum Dis ; 74(10): 1924-30, 2015 Oct.
Article em En | MEDLINE | ID: mdl-24936585
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Artrite Reumatoide / Membrana Sinovial / Receptores de Fator Estimulador das Colônias de Granulócitos e Macrófagos / Terapia de Alvo Molecular Tipo de estudo: Observational_studies / Prognostic_studies Limite: Adult / Aged / Animals / Female / Humans / Male / Middle aged Idioma: En Revista: Ann Rheum Dis Ano de publicação: 2015 Tipo de documento: Article País de afiliação: Holanda
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Artrite Reumatoide / Membrana Sinovial / Receptores de Fator Estimulador das Colônias de Granulócitos e Macrófagos / Terapia de Alvo Molecular Tipo de estudo: Observational_studies / Prognostic_studies Limite: Adult / Aged / Animals / Female / Humans / Male / Middle aged Idioma: En Revista: Ann Rheum Dis Ano de publicação: 2015 Tipo de documento: Article País de afiliação: Holanda